BaseSpace
Correlation
Engine-Public
Sign In
Register
Correlation Engine 2.0
Home
My Data
Bookmarks
Collaborations
Inbox
Import Your Data
QuickView
FAQ
What is QuickView?
What can my QuickView results tell me?
What are the sources for the General Info tab in QuickView?
More QuickView FAQs
Back to top
QuickView
Curated
Studies
Body
Atlas
Disease
Atlas
Pharmaco
Atlas
Knockdown
Atlas
Genetic
Markers
Pathway
Enrichment
Literature
Clinical
Trials
0
Meta-
Analysis
QuickView
Search sequence regions
(e.g.
Angiogenesis
,
Arthritis
,
Neuron
,
Autoimmunity
,
Doxorubicin
,
rs6983267
,
EGFR
)
Organisms
Chromosomes
Start
Stop
Homo Sapiens
Mus Musculus
Rattus Norvegicus
C. Elegans
D. Melanogaster
Saccharomyces Cerevisiae
QuickView
Go back to main search
Bookmark
Forward
QuickView
for
P2Y2
(gene)
Summary
General Info
Body Atlas
Most Correlated Tissues
Eosinophil of peripheral blood
Skeletal muscle
Jejunum
Skeletal muscle psoas
Rectum colon
Explore Body Atlas Results
Disease Atlas
Most Correlated Diseases
Rhinitis
Intestinal infectious disease
Infection due to Haemophilus
Abscess
Ascites
Explore Disease Atlas Results
Pharmaco Atlas
Most Correlated Compounds
propargite
MRK 003
cyclobenzaprine
pyridaben
difenzoquat sulfate (1:1)
Explore Pharmaco Atlas Results
Knockdown Atlas
Most Correlated Gene Perturbations
KLF13
HDGFL3
TERC
BMPR2
AHR
Explore Knockdown Atlas Results
Curated Studies
Most Correlated Studies
Loading...
Explore Curated Studies Results
Literature
Most Relevant Literature
Circulating Naturally Occurring Antibodies to P2RY2 Are Decreased in Alzheimer's Disease.
Aberrant Adenosine Triphosphate Release and Impairment of P2Y2-Mediated Signaling in Sarcoglycanopat…
P2RY2 Alleviates Cerebral Ischemia-Reperfusion Injury by Inhibiting YAP Phosphorylation and Reducing…
Establishment of a Cell Model for Dynamic Monitoring of Intracellular Calcium Concentration and High…
AKT/GSK-3beta/VEGF signaling is involved in P2RY2 activation-induced the proliferation and metastasi…
Explore Literature Results
Clinical Trials
Most Relevant Clinical Trials
Management of DE With IPL in Combination With DQS
Use of 3% Diquafosol Topical Ophthalmic Solution for Diabetic Dry Eye
Diquafosol Ophthalmic Solution for Dry Eye Symptoms
Diquafosol vs Hyaluronic Acid for Diabetic Dry Eye
Pyridoxine, P2 Receptor Antagonism, and ATP-mediated Vasodilation in Young Adults
Explore Clinical Trials Results
search
→
result
search
→
result
See more about this page
See complete FAQ